Reaction

Exposed Bone In Jaw reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,162 reports · 72 co-occurring drugs

As of the last recalculation, Exposed Bone In Jaw appears in 2,162 FAERS reports alongside 72 co-occurring drug terms. The strongest observed disproportionality signal is ZOLEDRONIC ACID (PRR 66.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Zoledronic Acid	247	66.7	67.2
Chlorhexidine Gluconate	57	61.7	62.0
Exemestane	65	30.1	30.2
Quinine	24	27.2	27.3
Denosumab	436	25.7	25.8
Bicalutamide	37	23.8	23.8
Alendronate Sodium Tablet	39	20.6	20.7
Fulvestrant	64	19.2	19.2
Clindamycin Phosphate	58	17.2	17.2
Meperidine Hydrochloride	16	16.8	16.9
Goserelin	23	16.7	16.7
Clindamycin	48	16.6	16.7
Alendronate Sodium	158	16.2	16.2
Thalidomide	57	15.3	15.3
Melphalan	35	15.0	15.1
Melphalan Hydrochloride	38	14.8	14.9
Letrozole	88	14.3	14.3
Sunitinib Malate	53	13.3	13.3
Anastrozole	49	13.1	13.1
Magnesium Hydroxide	16	11.5	11.5
Amoxicillin And Clavulanate Potassium	32	11.5	11.5
Ampicillin	9	10.5	10.5
Ampicillin Sodium	9	10.5	10.5
Everolimus Tablets	18	10.4	10.4
Methylprednisolone Acetate	8	9.6	9.7
Nystatin Ointment	25	9.3	9.3
Nystatin Cream	25	9.3	9.3
Dalteparin Sodium	10	9.1	9.1
Docusate Sodium - Sennosides	30	9.1	9.1
Cephalexin	20	9.0	9.0
Ezetimibe And Simvastatin	14	8.9	8.9
Nystatin	25	8.9	8.9
Temazepam	33	8.5	8.5
Erythropoietin	18	8.5	8.5
Capecitabine	76	8.2	8.3
Bortezomib	69	7.6	7.6
Losartan Potassium And Hydrochlorothiazide	9	7.5	7.5
Itraconazole	9	7.4	7.5
Cefazolin	7	7.4	7.4
Prochlorperazine	21	7.4	7.4
Dorzolamide Hydrochloride And Timolol Maleate	6	7.3	7.3
Everolimus	38	7.3	7.3
Sorafenib	14	6.5	6.5
Fluticasone Propionate And Salmeterol	27	6.3	6.3
Fondaparinux Sodium	5	6.0	6.0
Filgrastim	22	5.7	5.7
Oxycodone Hydrochloride And Acetaminophen	57	5.7	5.7
Lapatinib	9	5.6	5.6
Pazopanib Hydrochloride	15	5.4	5.4
Darbepoetin Alfa	28	5.1	5.1
Bevacizumab	63	5.0	5.0
Naproxen Sodium Tablet, Coated	7	5.0	5.0
Naproxen Sodium, Coated Tablets	7	5.0	5.0
Methadone	22	5.0	5.0
Naproxen Sodium 220Mg	7	5.0	5.0
Timolol	6	4.8	4.8
Eszopiclone	12	4.6	4.6
Trastuzumab	32	4.5	4.5
Gefitinib	4	4.3	4.3
Paclitaxel	43	4.2	4.2
Oxycodone Hydrochloride	89	4.1	4.1
Docetaxel Anhydrous	27	3.9	3.9
Docetaxel	27	3.9	3.9
Paclitaxel (Aibumin-Bound)	32	3.8	3.8
Conjugated Estrogens And Medroxyprogesterone Acetate	9	3.7	3.7
Loratadine And Pseudoephedrine Sulfate	3	3.6	3.6
Methadone Hydrochloride	4	3.6	3.6
Travoprost	3	3.3	3.3
Enzalutamide	16	2.6	2.6
Abiraterone Acetate	11	2.6	2.6
Axitinib	5	2.5	2.5
Lenalidomide	102	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.